Wednesday, July 8, 2026

pharma · Fertility · INTI

Inhibitor Therapeutics

Inhibitor Therapeutics clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Tampa, USA HQ
2013 Founded
5 Employees
Public company Type
INTI · NYSE Ticker
Company details
Status
Public
HQ
Tampa, USA
Founded
2013
Employees
5
Programs
2
Drugs
2
Patents
5
Intelligence · Clinical Programs

Inhibitor Therapeutics projects

2 ClinicalTrials.gov programs sponsored by Inhibitor Therapeutics.

Inhibitor Therapeutics has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Small RNA sequencing

    Inhibitor Therapeutics

    Fertility

    phase 1 gene therapy completed

    1 trial
  2. Window of Implantation

    Inhibitor Therapeutics

    IVF

    other active

    1 trial

Frequently asked questions

How many clinical projects does Inhibitor Therapeutics have?

2 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.